Published in Protein Sci on September 03, 2014
A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem (1978) 38.54
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Core structure of gp41 from the HIV envelope glycoprotein. Cell (1997) 16.18
Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol (1998) 14.83
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med (2000) 11.90
Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal Biochem (2000) 11.10
HIV vaccine design and the neutralizing antibody problem. Nat Immunol (2004) 9.48
HIV entry and its inhibition. Cell (1998) 9.42
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol (2001) 8.25
Tricine-SDS-PAGE. Nat Protoc (2006) 7.89
Lipid sorting in epithelial cells. Biochemistry (1988) 7.64
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med (2000) 7.48
New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues. J Chromatogr (1987) 6.17
Metal chelate affinity chromatography, a new approach to protein fractionation. Nature (1975) 5.83
Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc (2006) 5.81
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature (2012) 5.44
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science (2013) 4.61
Co-receptors for HIV-1 entry. Curr Opin Immunol (1997) 4.31
A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1994) 3.97
The HIV Env-mediated fusion reaction. Biochim Biophys Acta (2003) 3.37
Crystal structure of an isoleucine-zipper trimer. Nature (1994) 3.30
A Blueprint for HIV Vaccine Discovery. Cell Host Microbe (2012) 3.27
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med (2002) 3.04
The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim Biophys Acta (1998) 2.94
A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies. Proc Natl Acad Sci U S A (2008) 2.93
[The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)]. Zentralbl Bakteriol B (1978) 2.92
Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity (2011) 2.82
Release of proteins and peptides from fusion proteins using a recombinant plant virus proteinase. Anal Biochem (1994) 2.71
Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol (2002) 2.49
NMR structure of Mistic, a membrane-integrating protein for membrane protein expression. Science (2005) 2.41
Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions. PLoS Pathog (2010) 2.33
The 'immunologic advantage' of HIV-exposed seronegative individuals. AIDS (2009) 2.15
Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer. Proc Natl Acad Sci U S A (2013) 2.05
HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol (2011) 2.01
Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm. Retrovirology (2008) 1.89
Enveloped viruses: a common mode of membrane fusion?. Curr Biol (1997) 1.80
Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol (2000) 1.69
Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS (2000) 1.66
Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J Immunol (2001) 1.54
HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis. Mucosal Immunol (2009) 1.49
HIV-1 transmission in the male genital tract. Am J Reprod Immunol (2010) 1.35
HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide. J Biol Chem (2002) 1.28
Role of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infection. J Virol (2008) 1.28
HIV-1 gp41: mediator of fusion and target for inhibition. AIDS Rev (2004) 1.27
In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1. J Virol (2010) 1.25
The Escherichia coli multidrug transporter EmrE is a dimer in the detergent-solubilised state. J Mol Biol (2004) 1.23
Structure of the HIV-1 gp41 membrane-proximal ectodomain region in a putative prefusion conformation. Biochemistry (2009) 1.20
Early HIV-1 target cells in human vaginal and ectocervical mucosa. Am J Reprod Immunol (2010) 1.19
Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J Virol (2005) 1.19
GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium. J Immunol (2010) 1.15
HIV and the 7-transmembrane domain receptors. Pathobiology (1996) 1.14
Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state. Vaccine (2006) 1.12
Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane. J Virol (2012) 1.08
Biology of HIV mucosal transmission. Curr Opin HIV AIDS (2008) 1.06
Yeast mitochondrial ADP/ATP carriers are monomeric in detergents. Proc Natl Acad Sci U S A (2006) 1.06
Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions. AIDS (2002) 1.04
A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. Proc Natl Acad Sci U S A (2004) 1.04
Truncation of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein defines elements required for fusion, incorporation, and infectivity. J Virol (2009) 1.02
The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner. AIDS (2011) 1.01
Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate. Vaccine (2006) 1.00
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition. PLoS Pathog (2013) 0.97
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes. PLoS One (2013) 0.96
Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR. Plant Biotechnol J (2008) 0.95
Structural characterization of HIV gp41 with the membrane-proximal external region. J Biol Chem (2010) 0.95
Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptides. Eur Biophys J (2011) 0.93
HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies. PLoS One (2011) 0.93
Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action. PLoS One (2013) 0.88
Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration. J Biol Chem (2005) 0.86
Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes. Curr HIV Res (2008) 0.85
Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection. Adv Exp Med Biol (2013) 0.84
Residues in the membrane-spanning domain core modulate conformation and fusogenicity of the HIV-1 envelope glycoprotein. Virology (2010) 0.83
Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana. Plant Biotechnol J (2013) 0.79
Detailed topology mapping reveals substantial exposure of the "cytoplasmic" C-terminal tail (CTT) sequences in HIV-1 Env proteins at the cell surface. PLoS One (2013) 0.79
Expression, purification and crystallization of CTB-MPR, a candidate mucosal vaccine component against HIV-1. IUCrJ (2014) 0.78
Rational design of a fusion partner for membrane protein expression in E. coli. Protein Sci (2009) 0.78
Recombinant production and purification of the subunit c of chloroplast ATP synthase. Protein Expr Purif (2010) 0.77
Mucosal immunoglobulin A in HIV-exposed seronegative individuals. AIDS (2012) 0.76
Femtosecond X-ray protein nanocrystallography. Nature (2011) 14.34
High-resolution protein structure determination by serial femtosecond crystallography. Science (2012) 6.90
Femtosecond protein nanocrystallography-data analysis methods. Opt Express (2010) 4.64
Single mimivirus particles intercepted and imaged with an X-ray laser. Nature (2011) 4.63
Self-terminating diffraction gates femtosecond X-ray nanocrystallography measurements. Nat Photonics (2012) 3.68
Serial femtosecond crystallography of G protein-coupled receptors. Science (2013) 3.58
Self-assembling protein microarrays. Science (2004) 3.37
Proteome-scale purification of human proteins from bacteria. Proc Natl Acad Sci U S A (2002) 2.88
Structure-factor analysis of femtosecond microdiffraction patterns from protein nanocrystals. Acta Crystallogr A (2011) 2.86
Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc Natl Acad Sci U S A (2004) 2.81
Lipidic phase membrane protein serial femtosecond crystallography. Nat Methods (2012) 2.76
In vivo protein crystallization opens new routes in structural biology. Nat Methods (2012) 2.69
Next-generation high-density self-assembling functional protein arrays. Nat Methods (2008) 2.46
Many paths to many clones: a comparative look at high-throughput cloning methods. Genome Res (2004) 2.42
Time-resolved protein nanocrystallography using an X-ray free-electron laser. Opt Express (2012) 2.38
The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res (2005) 2.22
Analysis of genomic and proteomic data using advanced literature mining. J Proteome Res (2003) 2.16
Radiation damage in protein serial femtosecond crystallography using an x-ray free-electron laser. Phys Rev B Condens Matter Mater Phys (2011) 2.05
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae. Genome Res (2007) 1.75
Emerging tools for real-time label-free detection of interactions on functional protein microarrays. FEBS J (2005) 1.70
Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer. J Proteome Res (2006) 1.66
Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res (2008) 1.63
Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J Virol (2006) 1.53
A functional genomic yeast screen to identify pathogenic bacterial proteins. PLoS Pathog (2008) 1.46
A biomedically enriched collection of 7000 human ORF clones. PLoS One (2008) 1.39
DNASU plasmid and PSI:Biology-Materials repositories: resources to accelerate biological research. Nucleic Acids Res (2013) 1.33
Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays. Infect Immun (2009) 1.30
Fitting low-resolution cryo-EM maps of proteins using constrained geometric simulations. Biophys J (2007) 1.30
PSI:Biology-materials repository: a biologist's resource for protein expression plasmids. J Struct Funct Genomics (2011) 1.26
A full-genomic sequence-verified protein-coding gene collection for Francisella tularensis. PLoS One (2007) 1.26
c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1. Mol Cell (2007) 1.23
Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway. Nat Chem Biol (2006) 1.23
Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res (2013) 1.20
Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents. Proc Natl Acad Sci U S A (2010) 1.20
Light harvesting in photosystem I: modeling based on the 2.5-A structure of photosystem I from Synechococcus elongatus. Biophys J (2002) 1.19
Toward structure determination using membrane-protein nanocrystals and microcrystals. Methods (2011) 1.16
Protein Structure Initiative Material Repository: an open shared public resource of structural genomics plasmids for the biological community. Nucleic Acids Res (2009) 1.14
Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays. J Immunol Methods (2009) 1.10
Systematic analysis of the IgG antibody immune response against varicella zoster virus (VZV) using a self-assembled protein microarray. Mol Biosyst (2010) 1.09
Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol Cell Proteomics (2012) 1.08
High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A (2011) 1.07
High-throughput generation of P. falciparum functional molecules by recombinational cloning. Genome Res (2004) 1.07
Improving the accuracy of macromolecular structure refinement at 7 Å resolution. Structure (2012) 1.06
Structure of cyanobacterial photosystem I. Photosynth Res (2005) 1.06
Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology. Brain (2007) 1.06
A central repository for published plasmids. Science (2005) 1.06
Identification of functionally important negatively charged residues in the carboxy end of mouse hepatitis coronavirus A59 nucleocapsid protein. J Virol (2006) 1.06
PlasmID: a centralized repository for plasmid clone information and distribution. Nucleic Acids Res (2006) 1.05
Coordinating the impact of structural genomics on the human α-helical transmembrane proteome. Nat Struct Mol Biol (2013) 1.05
Identification and characterization of the tungsten-containing class of benzoyl-coenzyme A reductases. Proc Natl Acad Sci U S A (2009) 1.05
Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase. Plant Biotechnol J (2010) 1.05
Comparison of the light-harvesting networks of plant and cyanobacterial photosystem I. Biophys J (2005) 1.05
Data-directed top-down Fourier-transform mass spectrometry of a large integral membrane protein complex: photosystem II from Galdieria sulphuraria. Proteomics (2010) 1.04
A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. Proc Natl Acad Sci U S A (2004) 1.04
Bacterial cell-free system for high-throughput protein expression and a comparative analysis of Escherichia coli cell-free and whole cell expression systems. Protein Expr Purif (2004) 1.01
A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity. Biochemistry (2007) 1.01
Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate. Vaccine (2006) 1.00
Small-interfering RNAs from natural antisense transcripts derived from a cellulose synthase gene modulate cell wall biosynthesis in barley. Proc Natl Acad Sci U S A (2008) 0.99
Purification of transgenic plant-derived recombinant human acetylcholinesterase-R. Chem Biol Interact (2005) 0.98
Role of subunit NuoL for proton translocation by respiratory complex I. Biochemistry (2011) 0.97
Crystallization of the c14-rotor of the chloroplast ATP synthase reveals that it contains pigments. Biochim Biophys Acta (2008) 0.96
Role of the coronavirus E viroporin protein transmembrane domain in virus assembly. J Virol (2007) 0.96
Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR. Plant Biotechnol J (2008) 0.95
Serological autoantibody profiling of type 1 diabetes by protein arrays. J Proteomics (2013) 0.94
Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 A resolution. Protein Sci (2008) 0.93
Iron-sulfur cluster N7 of the NADH:ubiquinone oxidoreductase (complex I) is essential for stability but not involved in electron transfer. Biochemistry (2007) 0.93
Robust microarray production of freshly expressed proteins in a human milieu. Proteomics Clin Appl (2013) 0.93
Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologue. Biotechnol J (2013) 0.93
Draft Genome Sequence of the Filamentous Cyanobacterium Leptolyngbya sp. Strain Heron Island J, Exhibiting Chromatic Acclimation. Genome Announc (2014) 0.92
On-chip protein synthesis for making microarrays. Methods Mol Biol (2006) 0.91
Structure of plant photosystem I revealed by theoretical modeling. J Biol Chem (2005) 0.91
Adaptive changes in acetylcholinesterase gene expression as mediators of recovery from chemical and biological insults. Toxicology (2006) 0.91
Folding kinetics and structure of OEP16. Biophys J (2004) 0.90
A novel photosynthetic strategy for adaptation to low-iron aquatic environments. Biochemistry (2011) 0.90
Excitation migration in trimeric cyanobacterial photosystem I. J Chem Phys (2004) 0.90
Nucleic acid programmable protein array a just-in-time multiplexed protein expression and purification platform. Methods Enzymol (2011) 0.90
Docking of photosystem I subunit C using a constrained geometric simulation. J Am Chem Soc (2006) 0.89
Importance of the penultimate positive charge in mouse hepatitis coronavirus A59 membrane protein. J Virol (2007) 0.89
Dielectrophoretic sorting of membrane protein nanocrystals. ACS Nano (2013) 0.89
Importance of conserved cysteine residues in the coronavirus envelope protein. J Virol (2008) 0.89
Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath. FASEB J (2007) 0.88
Circulating and synovial antibody profiling of juvenile arthritis patients by nucleic acid programmable protein arrays. Arthritis Res Ther (2012) 0.88
Assembly of the Escherichia coli NADH:ubiquinone oxidoreductase (complex I). Biochim Biophys Acta (2008) 0.87
Crystallization of the large membrane protein complex photosystem I in a microfluidic channel. ACS Nano (2013) 0.87
A conserved domain in the coronavirus membrane protein tail is important for virus assembly. J Virol (2010) 0.86
Nucleotide-induced conformational changes in the Escherichia coli NADH:ubiquinone oxidoreductase (complex I). Biochem Soc Trans (2008) 0.86
Nucleic Acid programmable protein arrays: versatile tools for array-based functional protein studies. Curr Protoc Protein Sci (2011) 0.86
Electron tunneling rates in respiratory complex I are tuned for efficient energy conversion. Angew Chem Int Ed Engl (2015) 0.86
Measurement of small molecule binding kinetics on a protein microarray by plasmonic-based electrochemical impedance imaging. Anal Chem (2014) 0.85
Emerging protein array technologies for proteomics. Expert Rev Proteomics (2013) 0.85
A versatile protein microarray platform enabling antibody profiling against denatured proteins. Proteomics Clin Appl (2013) 0.85
Genetic analysis of the Photosystem I subunits from the red alga, Galdieria sulphuraria. Biochim Biophys Acta (2008) 0.85
Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes. Curr HIV Res (2008) 0.85
Development of a full-length human protein production pipeline. Protein Sci (2014) 0.84
Engineered Saccharomyces cerevisiae strain for improved xylose utilization with a three-plasmid SUMO yeast expression system. Plasmid (2008) 0.84
Biomarker discovery for heterogeneous diseases. Cancer Epidemiol Biomarkers Prev (2013) 0.84
Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome. J Proteome Res (2014) 0.83
High density diffusion-free nanowell arrays. J Proteome Res (2012) 0.83
Trichloroacetic acid (TCA) precipitation of proteins. Cold Spring Harb Protoc (2011) 0.83